Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
However, the Doha declaration does not take a decision on whether countries with insufficient or no manufacturing capacities in the pharmaceutical sector will be allowed to import generic drugs to deal with a health crisis. Instead, it calls upon the trips council to
agriculture remains the biggest source of inequity in the world trading system. Unlike telecom, financial, and legal services, farming practices in the North have stoutly resisted the logic of market forces. Farming in the North thrives on prodigious subsidies and price support systems combined with coddling protection through high tariffs …
Developing countries also fear the huge costs associated with greener technologies, which will be unbearable by their domestic industries. It could make their goods uncompetitive in western markets. This unequivocal opposition to greening of trade is what brings the motley crew of poor countries together. “If there’s one thing that …
they might well be the modern-day buccaneers. To further their research, agricultural and pharmaceutical companies often tap local communities for traditional knowledge relating to the use of biological resour ces. The conglomerates lose no time in appropriating this painstakingly assimilated information. And make a fast buck by developing products based …
the issue of access to drugs has shifted from anti aids drugs in Africa to anti anthrax drugs in the us. The us government is contemplating to override the patent on Ciprofloxacin, which is held by the German pharmaceutical company, Bayer and procure generic copies from other sources. This move …
Pharmacists and government officials in Nepal have expressed their concern about spurious and poor quality medicines that are doing the rounds in the country. According to officials of the Pharmaceutical Marketing Executive Association of Nepal (PEAN), the situation is particularly worse in the Terai region. "In some areas of Terai, …
The Brazilian government is planning to declare aids a national emergency. The country's health minister, Jose Serra, said the decision was made after negotiations to lower the price of nelfinavir, an aids drug manufactured by Hoffman-La Roche Incorporation, recently failed. The action is being taken under a legislation that permits …
The ongoing debate on the role of private funding for public research is of vital importance. Already, the prestigious scientific journal, Nature , has asked its authors to disclose any financial interests related to their studies. Thirteen leading medical journals, including New England Journal of Medicine, Lancet, Journal of the …
tiny bacterial parasites could serve as models for drugs effective against antibiotic-resistant bacteria, providing another line of defense against the threat of incurable diseases. The bacterial viruses, or bacteriophages, produce proteins that prevent bacteria from building an outer cell wall, reported researchers from Texas a&m University in the us. This …
pharmaceutical giant Cipla has introduced a three-in-one aids drug called Triomune. The new drug is a combination of stavudine, lamivudine and nevirapine. Cipla could synthesise the drug because Indian laws allow generic copies to be made. The generic drug would remain one of its kind, as the patent holders of …
indian laboratories are in a contemptible condition. Of the 367 laboratories that use animals for experiments, 300 lack basic facilities to house these animals, reveals an inspection of the Purpose of Control and Supervision of Experimental Animals (cpcsea). None of the 300 laboratories adhere to scientific protocols or standards while …
a killer disguised as a healer. This is how a us citizen described Baycol, a cholesterol-lowering drug, after 31 people died recently in the us due to its consumption. The medicine was, thereafter, withdrawn from the country's markets. The drug, manufactured by the German pharmaceutical giant Bayer ag, caused an …
The global pharmaceutical industry is feeling the heat. Following the industry's embarrassing withdrawal in April from a case against the South African government over the issue of access to cheap aids drugs, the us government dropped its complaint against Brazil's law dealing with the same issue at the World Trade …
Several eyebrows have been raised over the Cipla offer to supply anti- aids drugs at one-third the current price to developing countries like South Africa. On March 7, 2001 Cipla Ltd of Mumbai, formally requested the South African department of trade and industry to issue compulsory licenses to patents on …
Africa's first consignment of cheap generic antiretroviral drugs for treating AIDS was given to Kenya's Nyumbani Orphanage on June 12, 2001. "It's the beginning of the flow of medicines that have hitherto been prohibited,' said Angelo D'Agostino, a priest who runs the orphanage. Five-year-old Dickson, made history by becoming the …
the us Food and Drug Administration ( fda ) is planning to reintroduce Lotronex, a drug that was withdrawn from us markets in November 2000 because of its fatal side-effects. The drug is used to treat Irritable Bowel Syndrome ( ibs ), a debilitating disease characterised by excruciating pain in …
Fifteen US states have filed a US $100 million lawsuit against Aventis, a Franco-German drug group, and Andrx Pharmaceuticals Incorporation, an us generic drug maker. The suit alleges that Aventis paid Andrx almost US $90 million to delay the introduction of a cheaper generic version of one of Aventis' best-selling …
The Kenya Coalition for Access to Essential Medicines, a representative of all non-governmental organisations of the country, is putting pressure on the parliament to pass the Industrial Property Bill. This bill would allow the country to buy drugs at cheaper prices. Kenya's pharmaceutical industry has refused to sell life-saving drugs …
